Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Lactoferrin in Sepsis
NCT06181422Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Apr 2024
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin, lactoferrin in sepsis, sponsored by Tanta University. Started Apr 2024; status: recruiting.
02
Drugs
metforminlactoferrin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT06181422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06181422.